INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission ...Middle East

PLYMOUTH MEETING, Pa., May 23, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the European...

Hence then, the article about inovio announces orphan drug designation for ino 3107 for the treatment of recurrent respiratory papillomatosis from the european commission was published today ( Tuesday 23/05/2023 - 11:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission )

Also on site :

• Suspect in deadly San Jose police shooting identified
• Details emerge in crime spree that ended in deadly shootout with San Jose police
• Zelensky is ‘a man in a desperate position’ – Orban